SEARCH

SEARCH BY CITATION

References

  • 1
    Van Der Poel CL, Cuypers HT, Reesink HW. Hepatitis C virus six years on. Lancet 1994; 340: 14751479.
  • 2
    Di Bisceglie AM, Goodman ZD, Ishak KG, Hoofnagle JH, Melpolder JJ, Alter HJ. Long-term clinical and histopathological follow-up of chronic posttransfusion hepatitis. Hepatology 1991; 14: 969974.
  • 3
    Barrera JM, Bruguera M, Ercilla MG, Gil C, Celis R, Gil MP, Del Valle Onorato M, et al. Persistent hepatitis C viremia after acute self-limiting posttransfusion hepatitis C. Hepatology 1995; 21: 639644.
  • 4
    Tong MJ, El-Ferra NS, Reikes AR, Co RL. Clinical outcomes after transfusion-associated hepatitis C. N Engl J Med 1995; 332: 14631466.
  • 5
    Seeff LB, Buskell-Bales Z, Wright EC, Durako SJ, Alter HJ, Iber FL, Hollinger FB, et al. Long-term mortality after transfusion-associated non-A, non-B hepatitis. N Engl J Med 1992; 327: 19061911.
  • 6
    Verdon R, Pol S, Landais P, Mattlinger B, Carnot F, Brechot C, Busson M, et al. Absence of association between HLA antigens and chronicity of viral hepatitis in haemodialyzed patients. J Hepatol 1994; 21: 388393.
  • 7
    Maisonneuve P, Couroucé AM, Ferrer Le Coeur F, Guerois C, Laurian Y, Magniez M, Parquet-Gernez, et al. Anti-VHC et receveurs: situation chez les hémophiles en 1991. Rev Fr Tranfus Hémobiol 1992; 35: 193198.
  • 8
    Lucidarme D, Foutrein P, Creusy C, Forzy G, Foutrein-Comes MC, Muyssen A, Bailly D, et al. Prévalence des marqueurs des hépatites C, B et D et aspects histopathologiques dans un groupe de toxicomanes intraveineux. Gastroenterol Clin Biol 1994; 18: 964968.
  • 9
    Aymard JP, Botte C, Contal P, Janot C, Streiff F. Séroprévalence des anticorps contre le virus de l'hépatite C chez les donneurs de sang. Patho Biol 1993; 41: 149153.
  • 10
    Pillonel J, Couroucé AM, Laporte A, Brunet JB. Le dépistage du V.I.H, de la syphilis et des hépatites B et C dans les établissements de transfusion sanguine (E.T.S.). Bull Epidemiol Hebdo (France) 1992; 39: 185187.
  • 11
    Courouce AM. Séroconversion anti-VHC chez les donneurs de sang. La Gazette de la Transfusion 1995; 114: 115.
  • 12
    Roudot-Thoraval F, Deforges L, Girollet JP, Maria B, Milliez J, Pathier D, Duval J, et al. Prevalence des anticorps dirigés contre le virus de l'hépatite C (tests ELISA2 et RIBA2) dans une population de femmes enceintes France. Gastroenterol Clin Biol 1992; 16: 255259.
  • 13
    François M, Dubois F, Brand D, Bacq Y, Guerois C, Mouchet C, Tichet J, et al. Prevalence and significance of hepatitis C virus (HCV) viremia in HCV antibody-positive subjects from various populations. J Clin Microbiol 1993; 31: 11891193.
  • 14
    Levy PS, Lemeshow S. Sampling of Population, Methods and Application. New York: Wiley, 1991: 117148.
  • 15
    Harnett MD. Analysis of complex sample survey data: a software review. School of Public Health Sciences, University of Massachussetts, Amherst, 1994.
  • 16
    Dean AG, Dean JA, Coulombier D, Brendel KA, Smith DC, Burton AH, Dicker RC, et al. Epi Info, Version 6: a word processing, database, and statistics program for epidemiology on microcomputers. Centers for Disease Control and Prevention, Atlanta, GA, 1994.
  • 17
    Schlesselman JJ. Case-Control Studies: Design, Conduct and Analysis. New York: Oxford University Press, 1982.
  • 18
    Dow BC, Coote I, Munro H. Confirmation of Hepatitis C Virus antibody in blood donors. J Med Virol 1993; 41: 215220.
  • 19
    Goeser T, Müller HM, Solbach C, Gmelin K, Kurzen F, Kommerell B, Theilmann L. Prevalence and serological manifestation of hepatitis C virus infection in patients with hepatitis non-A, non-B: A follow-up study. Presse Méd 1994; 23: 793796.
  • 20
    Van der Poel CL, Cuypers HT, Reesink HW, Weiner AJ, Quan S, Di Nello R, Van Boven JJP, et al. Confirmation of hepatitis C virus infection by new four-antigen recombinant immunoblot assay. Lancet 1991; 337: 317319.
  • 21
    Pawlotsky JM, Fleury A, Choukroun V, Deforges F, Roudot-Thoraval F, Aumont P, Duval J, et al. Significance of highly positive c22-3 “Indeterminate” second-generation Hepatitis C Virus (HCV) Recombinant Immunoblot Assay (RIBA) and Resolution by Third-Generation HCV RIBA. J Clin Microbiol 1994; 32: 13741379.
  • 22
    McHutchison JG, Person JL, Govindarajan S, Valinluck B, Gore T, Lee SR, Nelles M, et al. Improved detection of hepatitis C virus antibodies in high-risk populations. Hepatology 1992; 15: 1925.
  • 23
    Pawlotsky JM, Maisonneuve P, Duval J, Dhumeaux D, Noel L. Significance of NS5-“indeterminate” third-generation anti-Hepatitis C virus serologic assays. Transfusion 1995; 35: 453454.
  • 24
    Uyttendaele S, Claeys H, Mertens W, Verhaert H, Vermylen C. Evaluation of third-generation screening and confirmatory assays for HCV antibodies. Vox Sang 1994; 66: 122129.
  • 25
    Desenclos JC, Dubois F, Couturier E, Pillonel J, Roudot-Thoraval F, Guignard E, Brunet JB, et al. Estimation du nombre de sujets infectés par le VHC en France 1994–1995. Bull Epidemiol Hebdo (France) 1996; 5: 2223.
  • 26
    Marin MG, Bresciani S, Puoti M, Rodella A, Gussago A, Ravaggi A, Pizzocolo G, et al. Clinical Significance of Serum Hepatitis C Virus (HCV) RNA as marker of HCV infection. J Clin Microbiol 1994; 32: 30083012.
  • 27
    Gonzalez A, Esteban JI, Madoz P, Viladomiu L, Genesca J, Muniz E, Enriquez J, et al. Efficacy of screening donors for antibodies to the hepatitis C virus to prevent transfusion-associated hepatitis: final report of a prospective trial. Hepatology 1995; 22: 439445.
  • 28
    Serfaty L, Giral P, Elghouzzi MH, Jullien AM, Poupon R. Risk factors for hepatitis C virus infection in hepatitis C virus antibody ELISA-positive blood donors according to RIBA-2 status: a case-control survey. Hepatology 1993; 17: 183187.
  • 29
    Donahue JG, Nelson KE, Munoz A, Vlahov D, Rennie LL, Taylor EL, Saah AJ, et al. Antibody to hepatitis C virus among cardiac surgery patients, homosexual men, and intravenous drug users in Baltimore, Maryland. Am J Epidemiol 1991; 134: 12061211.
  • 30
    Tedder RS, Gilson RJC, Briggs M, Loveday C, Cameron CH, Garson JA, Kelly GE, et al. Hepatitis C virus: evidence for sexual transmission. Br Med J 1991; 302: 12991302.
  • 31
    Kaldor JM, Archer GT, Buring ML, Ismay SL, Kenrick KG, Lien ASM, Purusothaman, et al. Risk-factors for hepatitis C virus infection in blood donors: a case-control study. Med J Aust 1992; 157: 227230.
  • 32
    Puoti C, Magrini A, Filippi T, Aldegheri L. Do symptomless HCV carriers spread infection to their relatives? Lancet 1995; 346: 843.
  • 33
    Alter MJ, Margolis HS, Krawczynski K, Judson FN, Mares A, Alexander WJ, Hu PY, et al. The natural history of community-acquired hepatitis C in the United States. N Engl J Med 1992; 327: 18991905.
  • 34
    Allander T, Gruber A, Naghavi M, Beyene A, Söderström T, Björkholm M, Grillner L. Frequent patient-to-patient transmission of hepatitis C virus in a haematology ward. Lancet 1995; 345: 603607.
  • 35
    Carpentier C, Costes JM. Drogues et toxicomanies: indicateurs et tendances. Délégation Générale à la Lutte Contre la Toxicomanie, Observatoire Français des Drogues et des toxicomanies, Paris, 1995: 5657.
  • 36
    Nousbaum JB, Pol S, Nalpas B, Landais P, Berthelot C And the Collaborative Study Group. Hepatitis C Virus type 1b (II) Infection in France and Italy. Ann Intern Med 1995; 122: 161168.
  • 37
    Pawlotsky JM, Tsarkiris L, Roudot-Thoraval F, Pellet C, Stuyver L, Duval J, Dhumeaux D. Relationship between hepatitis C virus genotypes and sources of infection in patients with chronic hepatitis C. J Infect Dis 1995; 171: 16071610.
  • 38
    Silini E, Bono F, Cividini A, Cerino A, Maccabruni A, Tinelli, Bruno S, et al. Molecular epidemiology of hepatitis C virus infection among intravenous drug users. J Hepatol 1995; 22: 691695.